Monetary Management Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Sell
15,685
-300
-2% -$35.1K 0.41% 54
2026
Q1
$1.92M Sell
15,985
-100
-0.6% -$11.5K 0.46% 49
2025
Q4
$1.69M Sell
16,085
-800
-5% -$75.1K 0.39% 55
2025
Q3
$1.42M Sell
16,885
-2,150
-11% -$177K 0.33% 63
2025
Q2
$1.51M Buy
19,035
+125
+0.7% +$9.94K 0.37% 62
2025
Q1
$1.7M Buy
18,910
+5,100
+37% +$476K 0.46% 48
2024
Q4
$1.37M Buy
13,810
+775
+6% +$79.9K 0.36% 65
2024
Q3
$1.48M Buy
13,035
+4,080
+46% +$485K 0.38% 61
2024
Q2
$1.11M Sell
8,955
-200
-2% -$25.8K 0.29% 75
2024
Q1
$1.21M Sell
9,155
-250
-3% -$30.8K 0.34% 73
2023
Q4
$1.03M Sell
9,405
-50
-0.5% -$5.19K 0.32% 81
2023
Q3
$973K Sell
9,455
-450
-5% -$48.5K 0.32% 74
2023
Q2
$1.14M Hold
9,905
0.35% 74
2023
Q1
$1.05M Buy
9,905
+250
+3% +$27K 0.31% 81
2022
Q4
$1.07M Sell
9,655
-274
-3% -$28K 0.33% 77
2022
Q3
$855K Hold
9,929
0.28% 90
2022
Q2
$905K Sell
9,929
-50
-0.5% -$4.43K 0.28% 82
2022
Q1
$819K Buy
9,979
+175
+2% +$13.8K 0.22% 94
2021
Q4
$751K Buy
9,804
+150
+2% +$11.9K 0.19% 99
2021
Q3
$725K Buy
9,654
+300
+3% +$22.8K 0.2% 98
2021
Q2
$727K Sell
9,354
-17,233
-65% -$1.28M 0.22% 97
2021
Q1
$1.96M Sell
26,587
-3,511
-12% -$259K 0.62% 43
2020
Q4
$2.35M Hold
30,098
0.77% 33
2020
Q3
$2.38M Sell
30,098
-5,502
-15% -$431K 0.85% 30
2020
Q2
$2.63M Buy
35,600
+78
+0.2% +$5.87K 0.99% 27
2020
Q1
$2.61M Buy
35,522
+1,704
+5% +$134K 1.15% 24
2019
Q4
$2.94M Buy
33,818
+5,769
+21% +$474K 1.07% 25
2019
Q3
$2.25M Buy
28,049
+15,951
+132% +$1.28M 0.85% 37
2019
Q2
$968K Sell
12,098
-419
-3% -$32.1K 0.37% 81
2019
Q1
$993K Buy
12,517
+524
+4% +$39.2K 0.39% 76
2018
Q4
$874K Buy
11,993
+1,755
+17% +$124K 0.39% 73
2018
Q3
$693K Buy
10,238
+131
+1% +$8.35K 0.26% 86
2018
Q2
$585K Sell
10,107
-131
-1% -$7.39K 0.24% 97
2018
Q1
$532K Sell
10,238
-1,886
-16% -$102K 0.22% 93
2017
Q4
$651K Buy
12,124
+288
+2% +$16K 0.26% 85
2017
Q3
$723K Buy
11,836
+2,934
+33% +$178K 0.3% 74
2017
Q2
$544K Buy
8,902
+4,140
+87% +$252K 0.22% 95
2017
Q1
$289K Sell
4,762
-9,223
-66% -$560K 0.13% 133
2016
Q4
$786K Sell
13,985
-341
-2% -$20K 0.36% 73
2016
Q3
$853K Buy
14,326
+209
+1% +$12.2K 0.39% 68
2016
Q2
$776K Buy
14,117
+5,901
+72% +$314K 0.36% 76
2016
Q1
$415K Buy
8,216
+3,091
+60% +$151K 0.2% 99
2015
Q4
$258K Hold
5,125
0.12% 128
2015
Q3
$242K Sell
5,125
-1,236
-19% -$65.7K 0.12% 130
2015
Q2
$346K Buy
6,361
+314
+5% +$17.6K 0.16% 119
2015
Q1
$332K Hold
6,047
0.15% 121
2014
Q4
$328K Sell
6,047
-419
-6% -$23.3K 0.15% 123
2014
Q3
$366K Hold
6,466
0.17% 115
2014
Q2
$357K Sell
6,466
-1,127
-15% -$61.5K 0.17% 117
2014
Q1
$411K Sell
7,593
-94
-1% -$4.87K 0.19% 110
2013
Q4
$367K Sell
7,687
-7,755
-50% -$354K 0.17% 118
2013
Q3
$702K Sell
15,442
-2,206
-13% -$101K 0.37% 81
2013
Q2
$782K Buy
+17,648
New +$788K 0.43% 75

Other funds holding MRK

Monetary Management Group's MRK Position: Q2 2026 in Review

Monetary Management Group reduced its Merck (MRK) stake by 1.9% in Q2 2026, selling an estimated $35.1K and leaving 15,685 shares worth $2.02M. The position accounts for 0.41% of the portfolio, ranked #54.

Monetary Management Group first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.94M in Q4 2019. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Monetary Management Group held 15,685 shares of Merck worth $2.02M as of Q2 2026.
  • Monetary Management Group sold 300 Merck shares in Q2 2026, an estimated $35.1K.
  • Merck made up 0.41% of Monetary Management Group's portfolio in Q2 2026, its #54 holding.
  • Monetary Management Group first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Monetary Management Group's Merck position peaked at $2.94M in Q4 2019.
  • 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Monetary Management Group's 13F filing for Q2 2026, filed 12 Aug 2026.